WHO ICTRP trial
Clinical study of the correlation between disease activity and anxious…
ChiCTR2300071418 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300071418 |
|---|---|
| Public title | Clinical study of the correlation between disease activity and anxious depression in patients with ankylosing spondylitis |
| Scientific title | Evaluation of the effectiveness of Tongdu Shujin Decoction combined with Adamumab in the treatment of ankylosing spondylitis and the correlation between patients' disease activity and anxious depression |
| Primary sponsor | The First Affiliated Hospital of Henan University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Ankylosing spondylits |
| Interventions | Tongdu Shujin decoction group: Tongdu Shujin Decoction a dose per day + adalimumab 40mg subcutaneously injected every two weeks for 12 weeks. ;Control group:Adalimumab was injected subcutaneously with 40mg every two weeks for 12 weeks. |
| Registration date | May 15, 2023 |
| Target size | Tongdu Shujin decoction group:40;Control group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: